Mandatory provider review and pain clinic laws reduce the amounts of opioids prescribed and overdose death rates

Dowell, Deborah, Zhang, Kun, Noonan, Rita K., Hockenberry, Jason M.·2016·Health Affairs
DOI 10.1377/hlthaff.2016.0448

Cited by (264)

Items 201–264 of 264

  1. The prescription drug monitoring program in a multifactorial approach to the opioid crisis: PDMP data, Pennsylvania, 2016–2020
    Jenna R. Adalbert, Amit Syal, Karan Varshney, Brandon J. George, Jeffrey K. Hom, Asif M. Ilyas · 2023 · BMC Health Services Research
  2. Learning from the implementation of a surgical opioid reduction initiative in an integrated health system: a qualitative study among providers and patients
    Willemijn L. A. Schäfer, Julie K. Johnson, Meagan L. Shallcross, Cassandra B. Iroz, Reiping Huang, Salva Najib Balbale, Jonah J. Stulberg · 2024 · Implementation Science Communications
  3. Barriers and motivational factors for engaging in novel opioid and medication disposal-related services in community pharmacies
    Mitchell J. Barnett, Brooke Hildebrand Clubbs, Ashley Woodyard, Valerie Wasem, Joyce Prinze, Anuradha Tirupasur, Sina Hosseini, Madison Kim, Faviola Gallardo, Natalie Polich et al. · 2024 · Research in Social and Administrative Pharmacy
  4. Effect of a Law Requiring Prescription Drug Monitoring Program Use on Emergency Department Opioid Prescribing: A Single-Center Analysis
    Abigail L. Zeiner, Michelle A. Burak, David M. O’Sullivan, Dayne Laskey · 2020 · Journal of Pharmacy Practice
  5. Fatal opioid overdoses in the U.S. declined more than reported between 2017 and 2018
    Andrew J. Boslett, Alina Denham, Elaine Hill · 2021 · The American Journal of Drug and Alcohol Abuse
  6. Examining Geographic Variation of Opioid Use Disorder Encounters in the USA
    Yifei Liu, Suman Sahil, Stacy L. Farr, Holly Hagle · 2022 · Advances in Therapy
  7. Prescription Drug Monitoring Programs and Opioid Death Rates—Reply
    Anne Schuchat, Gery P. Guy, Deborah Dowell · 2017 · JAMA
  8. How Well Do Doctors Know Their Patients? Evidence from a Mandatory Access Prescription Drug Monitoring Program
    Thomas C. Buchmueller, Colleen Marie Carey, Giacomo Meille · 2019 · National Bureau of Economic Research
  9. Coprescribing of opioids and high-risk medications in the USA: a cross-sectional study with data from national ambulatory and emergency department settings
    Kara Suvada, Anna Zimmer, Jesse A. Soodalter, Jimi S. Malik, Dio Kavalieratos, Mohammed Kumail Ali · 2022 · BMJ Open
  10. Prescription Opioid Resiliency and Vulnerability: A Mixed-Methods Comparative Case Study
    Andy Hochstetler, David J. Peters, Shannon M. Monnat · 2022 · American Journal of Criminal Justice
  11. Buprenorphine and opioid analgesics: Dispensation and discontinuity among accidental overdose fatalities in the Indianapolis metropolitan area, 2016–2021
    Grant A. Victor, Bradley R. Ray, Brandon del Pozo, Kaitlyn Jaffe, Andy King, Philip Huynh · 2023 · Journal of Substance Use and Addiction Treatment
  12. Tracking changes in opioid prescriptions dispensed following the enactment of a prescription drug monitoring program use mandate
    Arveen Kaur, David A. Mott, Aaron M. Gilson · 2023 · Research in Social and Administrative Pharmacy
  13. Impact of State Laws on Dispensing Opioid Prescriptions Following Posterior Lumbar Interbody Fusion Procedures: A Retrospective Large National Database Study
    Jamila A. Godil, Katrina Rapp, Spencer J. Smith, Won Hyung A. Ryu, Jung U. Yoo · 2023 · Global Spine Journal
  14. The effect of combat deployments on veteran opioid abuse
    Resul Cesur, Joseph J. Sabia, W. David Bradford · 2024 · Health Economics
  15. Spillover Effects From Health Information Systems Integration: Evidence From Prescription Drug Monitoring Programs
    Yufei Shen, Lianlian Jiang, Dimitrios Andritsos, Xitong Li · 2025 · Journal of Operations Management
  16. New Mexico Nurse‐Midwives’ Controlled Substance Prescribing and Monitoring Practices
    Katrina Nardini, Jenny Landen, Mark B. Parshall, Kim J. Cox · 2019 · Journal of Midwifery & Women s Health
  17. Prescription Opioid Misuse by Family Members: Implications for Nurse Practitioners
    Zhaoli Liu · 2020 · The Journal for Nurse Practitioners
  18. Die Opioidkrise in den USA: Ausmaß, Ursachen, Gegenmaßnahmen und die europäische Situation im Vergleich
    Ulrich W. Preuss, Friedrich Martin Wurst, Jessica Wong · 2020 · Suchttherapie
  19. A framework for tracking the distribution of increasingly abused pharmaceutical medications
    Opani Meshark Aweh, Oniyide Alabi Bello, Jason Omemu · 2022 · Journal of Contemporary International Relations and Diplomacy
  20. The butterfly effect: How an outpatient quality improvement project affected inpatient opioid‘s prescribing habits
    William J. Lorentzen, Natalie Perez, Colette Galet, Lauren D. Allan · 2022 · Surgery in Practice and Science
  21. State-level factors associated with implementation of prescription drug monitoring program integration and mandatory use policies, United States, 2009–2020
    Christian E Johnson, Elizabeth A. Chrischilles, Stephan V. Arndt, Ryan M. Carnahan · 2024 · Journal of the American Medical Informatics Association
  22. Prescription Drug Monitoring Programs and Opioid Death Rates
    William J. Rudman, Peter Corcoran, Kimberly Elliott · 2017 · JAMA
  23. Cycles of Chronic Opioid Therapy Following Mandatory Prescription Drug Monitoring Program Legislation: A Retrospective Cohort Study
    Bennett Allen, Victoria A. Jent, Magdalena Cerdá · 2022 · Journal of General Internal Medicine
  24. Examining the effect of prescription drug monitoring program integration and mandatory use policies on the distribution of methadone and buprenorphine for opioid use disorder, United States, 2009–2021
    Christian E. Johnson, George L. Wehby, Elizabeth A. Chrischilles, Stephan V. Arndt, Ryan M. Carnahan · 2024 · Drug and Alcohol Dependence
  25. Baclofen and opioid interactions in mice could inform pain treatment methods
    Stacie K. Totsch, R. Meir, Aaron R. Landis, Tammie L. Quinn, Robert E. Sorge · 2024 · Journal of Pharmacology and Experimental Therapeutics
  26. The association of state policies and opioid analgesic amount dispensed from retail pharmacies
    Bradley D. Stein, Flora Sheng, Erin Audrey Taylor, Corey S. Davis, Beth Ann Griffin, Mark Sorbero, Andrew W. Dick · 2025 · Drug and Alcohol Dependence
  27. Implementation of a novel pain coach educator program in a safety-net emergency department
    Jennifer H. LeLaurin, Magda Montague, Megan E. Curtis, Ramzi George Salloum, Sophia Sheikh, Phyllis L. Hendry · 2025 · Implementation Research and Practice
  28. Do Must-Access Prescription Drug Monitoring Programs (PDMPs) Affect Pain and Impairment Outcomes in Older Adults?
    Martha W. Wetzel, David H. Howard, Nicholas A. Giordano, Stephen W. Patrick, Courtney R. Yarbrough · 2025 · Medical Care Research and Review
  29. Co-occurring chronic pain and opioid use disorder diagnoses in the All of Us Research Program: associations with social determinants of health, mental health conditions, and polygenic liability
    Emma C. Johnson, Zhen Luo, Pamela N Romero Villela, Sukruth Kadaba, Nithya Sarabudla, Jared V. Balbona, Burel R. Goodin, Simon Haroutounian, Alexander Samir Hatoum, Arpana Agrawal A · 2026 · EBioMedicine
  30. Developing Opioid Prescription Guidelines After Anorectal Surgery: Do Patient-Reported Outcomes and Risk Factors Influence Consumption?
    Alison R. Althans, Katherine A. Hrebinko, Oluwatosin Olaitan, Maria Ettore, Kellie E. Cunningham, James P. Celebrezze, David Medich, Jennifer Holder‐Murray · 2021 · Diseases of the Colon & Rectum
  31. Fatal Toxicity Index, Total Prescriptions per Death, a Unique View of Medical Examiner Deaths and Prescription Monitoring Data
    2022 · Journal of Addiction Research
  32. A Shift Left: Revised Regulations for Opioid Prescribing in New Jersey
    Scott Metzger, Olivia Metzger · 2023 · Journal of Medical Regulation
  33. Discrepancies Between the Electronic Medical Record and Website Access to the Prescription Drug Monitoring Program
    Nelda P. Itzep, Ursula Campbell, Kevin Madden, Eduardo D Bruera · 2023 · Journal of Pain and Symptom Management
  34. The Implications of the Opioid Epidemic for the Treatment of Perioperative Pain
    Nan Xiang, Denise Courtney, Shivana Ramsingh, Rebecca Donald, Sudheer Potru · 2024 · Springer eBooks
  35. CTN-0138: adaptation, implementation, and cluster randomized trial of a Community Pharmacy-Based Prescription Drug Monitoring Program Opioid Risk Assessment Tool—a protocol paper
    Gerald Cochran, Jennifer L. Brown, Ziji Yu, Adam J. Gordon, Stacey M. Frede, Clinton J. Hardy, Melissa Castora‐Binkley, Felicity A. E. Homsted, Lisa A. Marsch, August F. Holtyn et al. · 2024 · Addiction Science & Clinical Practice
  36. Prescriber responses to a pain clinic law: Cease or modify?
    Jackie Yenerall, Melinda Beeuwkes Buntin · 2019 · Drug and Alcohol Dependence
  37. The Role of Prescription Drug Monitoring Programs (PDMPs) in Addressing the Opioid Overdose Epidemic
    Grant T. Baldwin, Jan L. Losby, Wesley M. Sargent, Jamie Mells, Sarah Bacon · 2019 · Oxford University Press eBooks
  38. Improving Estimates of the Quantity and Quality of Persons Involved in the Opioid Crisis
    A. D. Vaughan · 2020 · The Geojournal library
  39. The ER Doctor's Role in Combating the Opioid Epidemic.
    Matthew Gratton · 2017 · Europe PMC (PubMed Central)
  40. Privacy protections and law enforcement use of prescription drug monitoring databases
    Anne E. Boustead · 2021 · Law & Policy
  41. Characteristics and patterns of opioid-related overdoses among veterans
    Sara C. Warfield · 2019
  42. Opioid Overdoses in Indiana: A Closer Look at Opioid Type
    Harold E. Kooreman · 2018 · IUScholarWorks (Indiana University)
  43. Prescribing, Prescription Monitoring, and Health Policy
    Adam J. Gordon, Gerald Cochran, Marcela Carolina Smid, Ajay Manhapra, Stefan G. Kertesz · 2019 · Current clinical psychiatry
  44. Legal Issues in Pediatric Opioid Therapy
    Cobin D. Soelberg, HELEN NEWTON TURNER · 2020 · Springer eBooks
  45. Preventing Prescription Drug Abuse: A Pharmacy Technician Tool Kit
    Debbie L. Wilson · 2020 · Journal of Pharmacy Technology
  46. Essays on Prescription Drug Policy and Education as Determinants of Health
    Benjamin C. Ward · 2018
  47. The Effect of Unemployment Insurance Extensions on Population Mental Health: Evidence from the Great Recession
    Jie Chen, Xiaohui Guo, Lizhong Peng, Mengcen Qian · 2020 · SSRN Electronic Journal
  48. An Examination of Opioid Prescribing Policy and Clinical Practice in the Context of the United States Opioid Crisis
    Elizabeth C. Danielson · 2020 · IUScholarWorks (Indiana University)
  49. Providing Information Improved Adequate Storage and Disposal of Opioids by Bereaved Family Caregivers
    Ayumi Okizaki, Tomofumi Miura, Noriko Fujishiro, Naoko Igarashi, Yoshihisa Matsumoto, Akemi Shirado Naito, Yasuo Shima, Hiroya Kinoshita, Akhila Sunkepally Reddy, Tatsuya Morita et al. · 2021 · Research Square
  50. Gastritis erosiva por citomegalovirus en un lactante sano: puesta al día a propósito de un caso
    I. Carabaño Aguado, E. La Orden Izquierdo, F. J. Pelayo Baeza, José Fortes Alen, F. Manzarbeitia Arambarri · 2012 · Acta pediátrica española/Acta pediátrica española
  51. Does Algorithmic Risk Assessment Affect Physician Prescribing? Understanding Aggregate Versus Micro-Level Impacts
    Emma Boswell Dean, Ethan Mallick Hossain, Daniel Kaliski · 2024 · SSRN Electronic Journal
  52. Opioids today: From pharmacology to crisis management and emerging solutions
    Bijal Dharmesh Shah, Ronak Prakashchandra Gandhi, Darshan Narendra Lalwani, Pratik Sanjeev Bankhele, Priyanka Dattatraya Pathak · 2024 · World Journal of Biology Pharmacy and Health Sciences
  53. De-prescribing opioids among Medicaid patients with long-term opioid use
    Sarah A. Friedman, Paul M. Snyder, Denis Patterson, Sarah Y. T. Hartzell, Michelle S. Keller · 2025 · Journal of Substance Use and Addiction Treatment
  54. Relationship Between State Policies Targeting Unethical Treatment Practices and Opioid-Related Outcomes: An Event Study Analysis
    Melissa M. Garrido, Sivagaminathan Palani, PhiYen Nguyen, Kiersten L. Strombotne, Austin B. Frakt, Steven D. Pizer · 2025 · Substance Use &amp Addiction Journal
  55. Do Must-Access Prescription Drug Monitoring Programs (PDMPs) Affect Pain and Physical Impairment Outcomes in Older Adults?
    Martha W. Wetzel, David H. Howard, Nicholas A. Giordano, Stephen W. Patrick, Courtney R. Yarbrough · 2025 · medRxiv
  56. Association Between Health Plan Design and the Demand for Naloxone: Evidence From a Natural Experiment in New York
    Christopher Dunphy, Gaius Ahamide, Kun Zhang, Gery P. Guy · 2025 · American Journal of Preventive Medicine
  57. Understanding When and Where Overdoses Occur: A Data-Driven Framework for Community Response in Urban Areas
    Kim Michelle Lersch · 2025 · Urban Social Work
  58. Additional file of Protocol: mixed-methods study of how implementation of US state medical cannabis laws affects treatment of chronic non-cancer pain and adverse opioid outcomes
    McGinty, Emma E., Kayla N. Tormohlen, Colleen L. Barry, Mark C. Bicket, Lainie Rutkow, Elizabeth A. Stuart · 2021 · Figshare
  59. Additional file 2 of Efficacy of interventions targeted at physician prescribers of opioids for chronic non-cancer pain: an overview of systematic reviews
    Katya Peri, Lucy Honeycutt, Erica Wennberg, Sarah B. Windle, Kristian B. Filion, Gore, Genevieve, Irina Kudrina, Elena Paraskevopoulos, Areesha Moiz, Martel, Marc O. et al. · 2024 · Figshare
  60. Additional file 1 of Efficacy of interventions targeted at physician prescribers of opioids for chronic non-cancer pain: an overview of systematic reviews
    Peri, Katya, Lucy Honeycutt, Erica Wennberg, Sarah B. Windle, Kristian B. Filion, Gore, Genevieve, Irina Kudrina, Elena Paraskevopoulos, Areesha Moiz, Martel, Marc O. et al. · 2024 · Figshare
  61. Trend in Opioid Analgesic Prescriptions and High‐Risk Prescribing in the State of Illinois: An Eight‐Year Descriptive Analysis
    Linda Sangalli, C. Bolch, Marcia V. Rojas‐Ramirez · 2026 · Journal of Public Health Dentistry
  62. City Nuisance Ordinances and Overdose Mortality
    Ashley C. Bradford · 2026 · Journal of Policy Analysis and Management
  63. Experiences and Predictors of Real‐Time Prescription Drug Monitoring Program Use Among Australian Community Pharmacists: A Nationwide Study
    Louisa Picco, Monica Jung, Rose Laing, Jarrod McMaugh, Hester HK Wilson, Suzanne Nielsen · 2026 · Drug and Alcohol Review
  64. Opioid Pain Medication Use in Athletes
    LaRae L. Seemann, Rosa M. Pasculli, Oluseun A. Olufade, Shanterian King, Jason Lee, Mohit Chauhan, Amr R Saleh, George G.A. Pujalte · 2026 · Cureus